Localization of alpha 2 receptors in ocular tissues

Visual Neuroscience

Volumn 24, Issue 5, 2007, Pages 745-756

  Woldemussie, Elizabeth ^a   Wijono, Mercy ^b   Pow, David ^c  

^a PFIZER INC   (United States)

^b ALLERGAN INC   (United States)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Alpha 2 adrenergic receptors; Ciliary body; Human; Monkey; Polyclonal antibodies; Rat; Retina

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR;

ANIMAL TISSUE; ARTICLE; CILIARY BODY EPITHELIUM; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORNEA EPITHELIUM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEOMICS; RAT; RETINA; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANIMALS; ANTERIOR EYE SEGMENT; BLOTTING, WESTERN; CONJUNCTIVA; EYE; HAPLORHINI; HUMANS; IMMUNOHISTOCHEMISTRY; NEURONS; RABBITS; RATS; RECEPTORS, ADRENERGIC, ALPHA-2; RETINA;

EID: 35948964778     PISSN: 09525238     EISSN: 14698714     Source Type: Journal    
DOI: 10.1017/S0952523807070605     Document Type: Article

References (42)

1. AHMED, F.A., HEGAZY, K., CHAUDHARY, P. & SHARMA, S.C. (2001). Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure. Brain Research 913, 133-139.
2. BERLIE, J.R., IVERSEN, L.J., BLAXALL, H.S., COOLEY, M.E., CHACKO, D.M. & BYLUND, D.B. (1995). Alpha-2 adrenergic receptors in the bovine retina. Presence of only the alpha-2D subtype. Investigative Ophthalmology & Visual Science 36, 1885-1892.
3. BRUBAKER, R.F. (1991). Flow of aqueous humor in humans [The Friedenwald Lecture]. Investigative Ophthalmology & Visual Science 32, 3145-3166.
4. BURKE, J.A. & POTTER, D.E. (1986). Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys. Current Eye Research 5, 665-676.
5. BYLUND, D.B., BLAXALL, H.S., IVERSEN, L.J., CARON, M.G., LEFKOWITZ, R.J. & LOMASNEY, J.W. (1992). Pharmacological characteristics of alpha 2-adrenergic receptors: Comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Molecular Pharmacology 42, 1-5.
6. BYLUND, D.B. & CHACKO, D.M. (1999). Characterization of alpha2 adrenergic receptor subtypes in human ocular tissue homogenates. Investigative Ophthalmology & Visual Science 40, 2299-2306.
7. BYLUND, D.B., IVERSEN, L.J., MATULKA, W.J. & CHACKO, D.M. (1997). Characterization of alpha-2D adrenergic receptor subtypes in bovine ocular tissue homogenates. Journal of Pharmacology and Experimental Therapeutics 281, 1171-1177.
8. CHU, T.C. & CANDIA, O.A. (1988). Role of alpha 1- and alpha 2-adrenergic receptors in Cl- transport across frog corneal epithelium. American Journal of Physiology 255, C724-C730.
9. DONELLO, J.E., PADILLO, E.U., WEBSTER, M.L., WHEELER, L.A. & GIL, D.W. (2001). alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. Journal of Pharmacology and Experimental Therapeutics 296, 216-223.
10. ELENA, P.P., KOSINA-BOIX, M., DENIS, P., MOULIN, G. & LAPALUS, P. (1989). Alpha2-adrenergic receptors in rat and rabbit eye: A tritium-sensitive film autoradiography. Ophthalmic Research 21, 309-314.
11. ENRIQUEZ DE SALAMANCA, A., SIEMASKO, K.F., DIEBOLD, Y., CALONGE, M., GAO, J., JUAREZ-CAMPO, M. & STERN, M.E. (2005). Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium. Investigative Ophthalmology & Visual Science 46, 504-513.
12. HARRISON, J.K., D'ANGELO, D.D., ZENG, D.W. & LYNCH, K.R. (1991). Pharmacological characterization of rat alpha 2-adrenergic receptors. Molecular Pharmacology 40, 407-412.
13. HUANG, L., WEI, Y.Y., MOMOSE-H OTOKEZAKA, A., DICKEY, J. & OKUSA, M.D. (1996). Alpha 2B-adrenergic receptors: Immunolocalization and regulation by potassium depletion in rat kidney. American Journal of Physiology 270, F1015-1026.
14. HUANG, Y., GIL, D.W., VANSCHEEUWIJCK, P., STAMER, W.D. & REGAN, J.W. (1995). Localization of alpha 2-adrenergic receptor subtypes in the anterior segment of the human eye with selective antibodies. Investigative Ophthalmology & Visual Science 36, 2729-2739.
15. KALAPESI, F.B., CORONEO, M.T. & HILL, M.A. (2005). Human ganglion cells express the alpha-2 adrenergic receptor: Relevance to neuroprotection. British Journal of Ophthalmology 89, 758-763.
16. LAFUENTE, M.P., VILLEGAS-PEREZ, M.P., SELLES-NAVARRO, I., MAYOR-TORROGLOSA, S., MIRALLES DE IMPERIAL, J. & VIDAL-SANZ, M. (2002). Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult. Neuroscience 109, 157-168.
17. LAFUENTE, M.P., VILLEGAS-PEREZ, M.P., SOBRADO-CALVO, P., GARCIA-AVILES, A., MIRALLES DE IMPERIAL, J. & VIDAL-SANZ, M. (2001). Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death. Investigative Ophthalmology & Visual Science 42, 2074-2084.
18. LAI, R.K., CHUN, T., HASSON, D., LEE, S., MEHRBOD, F. & WHEELER, L. (2002). Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat. Visual Neuroscience 19, 175-185.
19. LEE, D.A., TOPPER, J.E. & BRUBAKER, R.F. (1984). Effect of clonidine on aqueous humor flow in normal human eyes. Experimental Eye Research 38, 239-246.
20. LEVKOVITCH-VERBIN, H., HARRIS-CERRUTI, C., GRONER, Y., WHEELER, L.A., SCHWARTZ, M. & YOLES, E. (2000). RGC death in mice after optic nerve crush injury: Oxidative stress and neuroprotection. Investigative Ophthalmology & Visual Science 41, 4169-4174.
21. MANNS, I.D., LEE, M.G., MODIRROUSTA, M., HOU, Y.P. & JONES, B.E. (2003). Alpha 2 adrenergic receptors on GABAergic, putative sleep-promoting basal forebrain neurons. European Journal of Neuroscience 18, 723-727.
22. MATSUO, T. & CYNADER, M.S. (1992). Localization of alpha-2 adrenergic receptors in the human eye. Ophthalmic Research 24, 213-219.
23. MAUS, T.L., NAU, C. & BRUBAKER, R.F. (1999). Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents. Archive of Ophthalmology 117, 586-591.
24. OGIDIGBEN, M., CHU, T.C. & POTTER, D.E. (1994). Alpha-2 adrenoceptor mediated changes in aqueous dynamics: Effect of pertussis toxin. Experimental Eye Research 58, 729-736.
25. OSBORNE, N.N. (1982). Binding of (-)[3H]noradrenaline to bovine membrane of the retina. Evidence for the existence of alpha 2-receptors. Vision Research 22, 1401-1407.
26. POW, D.V. & CROOK, D.K. (1993). Extremely high titre polyclonal antisera against small neurotransmitter molecules: Rapid production, characterisation and use in light- and electron-microscopic immunocytochemistry. Journal of Neuroscience Methods 48, 51-63.
27. POW, D.V. & HENDRICKSON, A.E. (1999). Distribution of the glycine transporter glyt-1 in mammalian and nonmammalian retinae. Visual Neuroscience 16, 231-239.
28. RAUEN, T., TAYLOR, W.R., KUHLBRODT, K. & WIESSNER, M. (1998). High-affinity glutamate transporters in the rat retina: A major role of the glial glutamate transporter GLAST-1 in transmitter clearance. Cell Tissue Research 291, 19-31.
29. RICHMAN, J.G., BRADY, A.E., WANG, Q., HENSEL, J.L., COLBRAN, R.J. & LIMBIRD, L.E. (2001). Agonist-regulated Interaction between alpha2-adrenergic receptors and spinophilin. Journal of Biological Chemistry 276, 15003-15008.
30. SCHADLU, R., MAUS, T.L., NAU, C.B. & BRUBAKER, R.F. (1998). Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans. Archive of Ophthalmology 116, 1441-1444.
31. SERLE, J.B., STEIDL, S., WANG, R.F., MITTAG, T.W. & PODOS, S.M. (1991). Selective alpha 2-adrenergic agonists B-HT 920 and UK14304-18. Effects on aqueous humor dynamics in monkeys. Archive of Ophthalmology 109, 1158-1162.
32. STONE, L.S., BROBERGER, C., VULCHANOVA, L., WILCOX, G.L., HOKFELT. T., RIEDL. M.S. & ELDE, R. (1998). Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. Journal of Neuroscience 18, 5928-5937.
33. TORIS, C.B., GLEASON, M.L., CAMRAS, C.B. & YABLONSKI, M.E. (1995). Effects of brimonidine on aqueous humor dynamics in human eyes. Archive of Ophthalmology 113, 1514-1517.
34. VIDAL-SANZ, M., LAFUENTE, M.P., MAYOR-TORROGLOSA, S., AGUILERA, M.E., MIRALLES DE IMPERIAL, J. & VILLEGAS-PEREZ, M.P. (2001a). Brimonidine's neuroprotective effects against transient ischaemiainduced retinal ganglion cell death. European Journal of Ophthalmology 11, S36-S40.
35. VIDAL-SANZ, M., LAFUENTE, M.P., MAYOR, S., DE IMPERIAL, J.M. & VILLEGAS-PEREZ, M.P. (2001b). Retinal ganglion cell death induced by retinal ischemia. neuroprotective effects of two alpha-2 agonists. Survey of Ophthalmology 45, S261-S267.
36. WEN, R., CHENG, T., LI, Y., CAO, W. & STEINBERG, R.H. (1996). Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage. Journal of Neuroscience 16, 5986-5992.
37. WHEELER, L.A., GILM, D.W. & WOLDEMUSSIE, E. (2001). Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma. Survey of Ophthalmology 45, S290-S294.
38. WHEELER, L.A., LAI, R. & WOLDEMUSSIE, E. (1999). From the lab to the clinic: Activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury. European Journal of Ophthalmology 9, S17-S21.
39. WHEELER, L.A. & WOLDEMUSSIE, E. (2001). Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma. European Journal of Ophthalmology 11, S30-S35.
40. WOLDEMUSSIE, E., RUIZ, G., WIJONO, M. & WHEELER, L.A. (2001). Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Investigative Ophthalmology & Visual Science 42, 2849-2855.
41. YOLES, E., WHEELER, L.A. & SCHWARTZ, M. (1999). Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Investigative Ophthalmology & Visual Science 40, 65-73.
42. ZARBIN, M.A., WAMSLEY, J.K., PALACIOS, J.M. & KUHAR, M.J. (1986). Autoradiographic localization of high affinity GABA, benzodiazepine, dopaminergic, adrenergic and muscarinic cholinergic receptors in the rat, monkey and human retina. Brain Research 374, 75-92.